While cannabis stocks continue their selloff today, biotech stocks are moving higher, with one in particular in the spotlight. On Monday, June 24, NERV stock jumped more than 40% in mid-day trade; this occurred after Minerva Neurosciences (NASDAQ:NERV) said its trial of Seltorexant met its principal goals.
Here’s everything we know.
NERV Stock Goes Flying on Seltorexant Trial NewsToday, Minerva Neurosciences said its Seltorexant trial met its primary and secondary goals. Seltorexant is the company’s treatment for insomnia; Minerva hosted a conference call on the matter at 8:30 AM EDT Monday. According to ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.